• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Increasing trend of transmitted integrase inhibitor resistance in a cohort of antiretroviral therapy-naive people living with HIV.

作者信息

Muccini Camilla, Galli Laura, Sampaolo Michela, Gianotti Nicola, Castagna Antonella, Canetti Diana

机构信息

Department of Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Vita-Salute San Raffaele University, via Stamira D'Ancona 20, Milan 20127, Italy.

出版信息

J Antimicrob Chemother. 2023 May 3;78(5):1314-1315. doi: 10.1093/jac/dkad109.

DOI:10.1093/jac/dkad109
PMID:37029656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10243965/
Abstract
摘要

相似文献

1
Increasing trend of transmitted integrase inhibitor resistance in a cohort of antiretroviral therapy-naive people living with HIV.在一群未接受过抗逆转录病毒治疗的艾滋病毒感染者中，传播的整合酶抑制剂耐药性呈上升趋势。
J Antimicrob Chemother. 2023 May 3;78(5):1314-1315. doi: 10.1093/jac/dkad109.
2
[HIV-1 integrase inhibitor resistance among treatment naïve patients in Gran Canaria, 2017].[2017年大加那利岛初治患者中HIV-1整合酶抑制剂耐药情况]
Rev Esp Quimioter. 2018 Oct;31(5):459-460. Epub 2018 Sep 17.
3
Novel integrase inhibitors for HIV.新型 HIV 整合酶抑制剂。
Expert Opin Investig Drugs. 2010 Sep;19(9):1087-98. doi: 10.1517/13543784.2010.501078.
4
Short Communication: Trends in Transmitted Drug Resistance in Treatment-Naive HIV Patients in Korea.简短通讯：韩国初治HIV患者中传播耐药性的趋势
AIDS Res Hum Retroviruses. 2020 Nov;36(11):905-909. doi: 10.1089/AID.2020.0054. Epub 2020 Sep 7.
5
Mutations in the HIV-1 3'-Polypurine Tract and Integrase Strand Transfer Inhibitor Resistance.HIV-1 3'-多聚嘌呤序列突变与整合酶链转移抑制剂耐药性
Antimicrob Agents Chemother. 2021 May 18;65(6). doi: 10.1128/AAC.02432-20.
6
Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation.超深度测序检测R263K整合酶抑制剂耐药突变
J Antimicrob Chemother. 2017 May 1;72(5):1537-1539. doi: 10.1093/jac/dkw571.
7
Characterization and structural analysis of HIV-1 integrase conservation.HIV-1整合酶保守性的表征与结构分析
AIDS Rev. 2009 Jan-Mar;11(1):17-29.
8
Short Communication: HIV-1 Drug Resistance Mutation Analyses of Cameroon-Derived Integrase Sequences.短讯：喀麦隆来源整合酶序列的 HIV-1 耐药突变分析。
AIDS Res Hum Retroviruses. 2021 Jan;37(1):54-56. doi: 10.1089/AID.2020.0022. Epub 2020 Aug 10.
9
Integrase Strand Transfer Inhibitor Resistance Mutations in Antiretroviral Therapy-Naive and Treatment-Experienced HIV Patients in South Korea.韩国初治和经治HIV患者中抗逆转录病毒治疗整合酶链转移抑制剂耐药突变情况
AIDS Res Hum Retroviruses. 2019 Feb;35(2):213-216. doi: 10.1089/AID.2018.0213. Epub 2018 Oct 23.
10
Integrase-resistant HIV in an antiretroviral-naive patient in Australia.澳大利亚一名初治抗逆转录病毒治疗患者体内的整合酶耐药型艾滋病毒。
AIDS. 2017 Feb 20;31(4):598-600. doi: 10.1097/QAD.0000000000001377.

引用本文的文献

1
Next-Generation Sequencing Analysis for HIV-1 Genotyping and Drug Resistance Mutations Mapping in Sicily, Italy.意大利西西里岛HIV-1基因分型及耐药突变图谱的新一代测序分析
Viruses. 2025 Aug 18;17(8):1129. doi: 10.3390/v17081129.
2
Do we need routine integrase resistance testing before starting antiretroviral therapy?在开始抗逆转录病毒治疗之前，我们是否需要进行常规的整合酶耐药性检测？
Lancet HIV. 2025 Jun 17. doi: 10.1016/S2352-3018(25)00108-0.
3
Treatment of Advanced HIV in the Modern Era.现代时代晚期HIV的治疗

本文引用的文献

1
Pre-Treatment Integrase Inhibitor Resistance and Natural Polymorphisms among HIV-1 Subtype C Infected Patients in Ethiopia.埃塞俄比亚 HIV-1 型 C 亚型感染患者的治疗前整合酶抑制剂耐药性和自然多态性。
Viruses. 2022 Mar 30;14(4):729. doi: 10.3390/v14040729.
2
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021.欧洲艾滋病临床学会指南 2021 年第 11.0 次重大修订版。
HIV Med. 2022 Sep;23(8):849-858. doi: 10.1111/hiv.13268. Epub 2022 Mar 25.
3
Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings.
Drugs. 2025 May 12. doi: 10.1007/s40265-025-02181-1.
4
Pretreatment HIV Drug Resistance to Integrase Strand Transfer Inhibitors Among Newly Diagnosed HIV Individuals - China, 2018-2023.2018 - 2023年中国新诊断HIV感染者中对整合酶链转移抑制剂的治疗前HIV耐药情况
China CDC Wkly. 2025 Jan 10;7(2):31-39. doi: 10.46234/ccdcw2025.007.
5
Role of the pharmacist caring for people at risk of or living with HIV in Canada.加拿大药剂师在照顾有感染艾滋病毒风险或感染艾滋病毒的人群方面的作用。
Can Pharm J (Ott). 2024 Aug 2;157(5):218-239. doi: 10.1177/17151635241267350. eCollection 2024 Sep-Oct.
6
Practical updates in clinical antiviral resistance testing.临床抗病毒耐药性检测的实用更新。
J Clin Microbiol. 2024 Aug 14;62(8):e0072823. doi: 10.1128/jcm.00728-23. Epub 2024 Jul 25.
喀麦隆 HIV-1 各亚型中整合酶耐药突变和保守区的基线情况：对资源有限环境中向多替拉韦转换的影响。
J Antimicrob Chemother. 2021 Apr 13;76(5):1277-1285. doi: 10.1093/jac/dkab004.
4
Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society-USA Panel.人类免疫缺陷病毒耐药性：美国国际抗病毒学会 2018 年推荐意见。
Clin Infect Dis. 2019 Jan 7;68(2):177-187. doi: 10.1093/cid/ciy463.
5
Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa.撒哈拉以南非洲地区感染多种 HIV-1 亚型的患者对整合酶链转移抑制剂的原发性耐药。
J Antimicrob Chemother. 2018 May 1;73(5):1167-1172. doi: 10.1093/jac/dky005.
6
Primary resistance to integrase strand-transfer inhibitors in Europe.欧洲对整合酶链转移抑制剂的原发性耐药性。
J Antimicrob Chemother. 2015 Oct;70(10):2885-8. doi: 10.1093/jac/dkv202. Epub 2015 Jul 17.
7
The Impact of HIV Genetic Polymorphisms and Subtype Differences on the Occurrence of Resistance to Antiretroviral Drugs.人类免疫缺陷病毒（HIV）基因多态性和亚型差异对抗逆转录病毒药物耐药性发生的影响
Mol Biol Int. 2012;2012:256982. doi: 10.1155/2012/256982. Epub 2012 Jun 26.